ID   PACE1_HUMAN             Reviewed;         742 AA.
AC   Q8IZE3; A8K8Z2; Q5THA6; Q5THA8; Q8IZN9; Q96C56; Q9UBK6;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-NOV-2010, entry version 79.
DE   RecName: Full=Protein-associating with the carboxyl-terminal domain of ezrin;
DE   AltName: Full=Ezrin-binding protein PACE-1;
DE   AltName: Full=SCY1-like protein 3;
GN   Name=SCYL3; Synonyms=PACE1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, INTERACTION
RP   WITH EZR, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, PHOSPHORYLATION,
RP   MYRISTOYLATION AT GLY-2, MUTAGENESIS OF 2-GLU--SER-6, AND VARIANT
RP   ARG-621.
RC   TISSUE=Kidney;
RX   PubMed=12651155; DOI=10.1016/S0014-4827(02)00054-X;
RA   Sullivan A., Uff C.R., Isacke C.M., Thorne R.F.;
RT   "PACE-1, a novel protein that interacts with the C-terminal domain of
RT   ezrin.";
RL   Exp. Cell Res. 284:224-238(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Rhodes S., Huckle E.;
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-621.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-621.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ALA-597.
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May play a role in regulating cell adhesion/migration
CC       complexes in migrating cells.
CC   -!- SUBUNIT: Interacts with EZR/VIL2 C-terminal domain.
CC   -!- INTERACTION:
CC       P15311:EZR; NbExp=2; IntAct=EBI-1380680, EBI-1056902;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Golgi apparatus. Cell projection,
CC       lamellipodium. Note=Colocalized with EZR/VIL2, actin and CD44 in
CC       lamellipodia.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IZE3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IZE3-2; Sequence=VSP_013125;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- PTM: May be myristoylated; myristoylation may target it to Golgi
CC       compartment.
CC   -!- PTM: Phosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC   -!- SIMILARITY: Contains 4 HEAT repeats.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF540957; AAN23123.1; -; mRNA.
DR   EMBL; AY144493; AAN41656.1; -; mRNA.
DR   EMBL; AL117233; CAB55300.1; -; mRNA.
DR   EMBL; AK292507; BAF85196.1; -; mRNA.
DR   EMBL; AL031297; CAB52564.2; -; Genomic_DNA.
DR   EMBL; AL031297; CAI23517.1; -; Genomic_DNA.
DR   EMBL; AL031297; CAI23518.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW90867.1; -; Genomic_DNA.
DR   EMBL; BC014662; AAH14662.1; -; mRNA.
DR   IPI; IPI00217989; -.
DR   IPI; IPI00237463; -.
DR   RefSeq; NP_065156.5; -.
DR   RefSeq; NP_851607.2; -.
DR   UniGene; Hs.435560; -.
DR   ProteinModelPortal; Q8IZE3; -.
DR   SMR; Q8IZE3; 25-259, 375-412.
DR   IntAct; Q8IZE3; 6.
DR   STRING; Q8IZE3; -.
DR   PhosphoSite; Q8IZE3; -.
DR   PRIDE; Q8IZE3; -.
DR   Ensembl; ENST00000367770; ENSP00000356744; ENSG00000000457.
DR   Ensembl; ENST00000367772; ENSP00000356746; ENSG00000000457.
DR   GeneID; 57147; -.
DR   KEGG; hsa:57147; -.
DR   NMPDR; fig|9606.3.peg.2600; -.
DR   UCSC; uc001ggs.2; human.
DR   UCSC; uc001ggt.2; human.
DR   CTD; 57147; -.
DR   GeneCards; GC01M169821; -.
DR   HGNC; HGNC:19285; SCYL3.
DR   HPA; HPA005624; -.
DR   MIM; 608192; gene.
DR   PharmGKB; PA142670945; -.
DR   eggNOG; prNOG12006; -.
DR   HOGENOM; HBG714631; -.
DR   HOVERGEN; HBG053485; -.
DR   InParanoid; Q8IZE3; -.
DR   OMA; WPDWSEP; -.
DR   OrthoDB; EOG90ZTJ7; -.
DR   PhylomeDB; Q8IZE3; -.
DR   NextBio; 63101; -.
DR   ArrayExpress; Q8IZE3; -.
DR   Bgee; Q8IZE3; -.
DR   CleanEx; HS_SCYL3; -.
DR   Genevestigator; Q8IZE3; -.
DR   GermOnline; ENSG00000000457; Homo sapiens.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0016477; P:cell migration; NAS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR021133; HEAT_type_2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   Gene3D; G3DSA:1.25.10.10; ARM-like; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50077; HEAT_REPEAT; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Complete proteome; Cytoplasm;
KW   Golgi apparatus; Lipoprotein; Myristate; Phosphoprotein; Polymorphism;
KW   Repeat.
FT   INIT_MET      1      1       Removed (Probable).
FT   CHAIN         2    742       Protein-associating with the carboxyl-
FT                                terminal domain of ezrin.
FT                                /FTId=PRO_0000058167.
FT   DOMAIN        2    245       Protein kinase.
FT   REPEAT      199    238       HEAT 1.
FT   REPEAT      285    323       HEAT 2.
FT   REPEAT      333    370       HEAT 3.
FT   REPEAT      372    409       HEAT 4.
FT   REGION      548    742       Interaction with EZR.
FT   MOD_RES     476    476       Phosphoserine (By similarity).
FT   LIPID         2      2       N-myristoyl glycine (Probable).
FT   VAR_SEQ     438    491       Missing (in isoform 2).
FT                                /FTId=VSP_013125.
FT   VARIANT     597    597       G -> A (in dbSNP:rs12143301).
FT                                /FTId=VAR_051690.
FT   VARIANT     621    621       Q -> R (in dbSNP:rs4656197).
FT                                /FTId=VAR_051691.
FT   MUTAGEN       2      6       GSENS->M: No Golgi targeting, accumulates
FT                                in the cytoplasm.
FT   CONFLICT    613    613       M -> T (in Ref. 1; AAN23123/AAN41656).
SQ   SEQUENCE   742 AA;  82857 MW;  2F7D03681A4F641B CRC64;
     MGSENSALKS YTLREPPFTL PSGLAVYPAV LQDGKFASVF VYKRENEDKV NKAAKHLKTL
     RHPCLLRFLS CTVEADGIHL VTERVQPLEV ALETLSSAEV CAGIYDILLA LIFLHDRGHL
     THNNVCLSSV FVSEDGHWKL GGMETVCKVS QATPEFLRSI QSIRDPASIP PEEMSPEFTT
     LPECHGHARD AFSFGTLVES LLTILNEQVS ADVLSSFQQT LHSTLLNPIP KCRPALCTLL
     SHDFFRNDFL EVVNFLKSLT LKSEEEKTEF FKFLLDRVSC LSEELIASRL VPLLLNQLVF
     AEPVAVKSFL PYLLGPKKDH AQGETPCLLS PALFQSRVIP VLLQLFEVHE EHVRMVLLSH
     IEAYVEHFTQ EQLKKVILPQ VLLGLRDTSD SIVAITLHSL AVLVSLLGPE VVVGGERTKI
     FKRTAPSFTK NTDLSLEDSP MCVVCSHHSQ ISPILENPFS SIFPKCFFSG STPINSKKHI
     QRDYYNTLLQ TGDPFSQPIK FPINGLSDVK NTSEDSENFP SSSKKSEEWP DWSEPEEPEN
     QTVNIQIWPR EPCDDVKSQC TTLDVEESSW DDCEPSSLDT KVNPGGGITA TKPVTSGEQK
     PIPALLSLTE ESMPWKSSLP QKISLVQRGD DADQIEPPKV SSQERPLKVP SELGLGEEFT
     IQVKKKPVKD PEMDWFADMI PEIKPSAAFL ILPELRTEMV PKKDDVSPVM QFSSKFAAAE
     ITEGEAEGWE EEGELNWEDN NW
//
